`

TScan Therapeutics

Biotechnology Research

Specialities :
Tcr-t cell therapy
revenue-icon Revenue
1M - 10M
funding-icon Total Funding
$150.0M
size-icon Size
51 - 200

Frequently Asked Questions About TScan Therapeutics

What does Tscan therapeutics do?+

TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system. TScan Therapeutics was founded in 2018 by a small group of scientists led by Dr. Stephen Elledge (Harvard Medical School/HHMI). TScan is discovering and developing novel TCR-engineered T cell therapies for the treatment of cancer. Our discovery platform is centered around a breakthrough technology that enables the rapid, comprehensive, and genome-wide identification of the peptide antigen targets of T cell receptors. This technology greatly enhances our ability to understand the specific antigens that drive important disease processes, including tumor...

What are Tscan therapeutics's specialties? +

Tcr-t cell therapy

What is Tscan therapeutics's industry? +

Tscan therapeutics operates in the Biotechnology research industry.

What is Tscan therapeutics's revenue? +

Tscan therapeutics's revenue is 1m - 10m

What is Tscan therapeutics's company size? +

Tscan therapeutics has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.